Patent Assignment
Reel/Frame 059990/0925
Assignment of Assignor's Interest
Recorded: 2022-05-23
Pages: 2
Assignors
HAZEN, STANLEY L
Executed: 2012-02-13
WANG, ZENENG
Executed: 2012-02-14
LEVISON, BRUCE L
Executed: 2012-02-13
Assignee
THE CLEVELAND CLINIC FOUNDATION
9500 EUCLID AVENUE, CLEVELAND, OHIO, 44195
Covered Property
(1)
Tma-Formation Inhibitor Treatment for Elevated Tma-Containing Compound Diseases
Related Assignments
(2)
Other recorded transfers of the patent in this record — the chain of ownership.
Corrective Assignment to Correct the the Typo in the Third Inventor's Name Previously Recorded at Reel: 059990 Frame: 0925. Assignor(S) Hereby Confirms the Assignment.
Jul 29, 2022
From: HAZEN, STANLEY L; WANG, ZENENG; LEVISON, BRUCE S
To: THE CLEVELAND CLINIC FOUNDATION
Reel/Frame 061003/0906 →
Confirmatory License
Nov 10, 2023
From: CLEVELAND CLINIC FOUNDATION
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 065548/0091 →